Commonwealth Equity Services’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-41,260
| Closed | -$35K | – | 3051 |
|
|
2019
Q4 | $35K | Buy |
41,260
+24,580
| +147% | +$18.9K | ﹤0.01% | 2831 |
|
|
2019
Q3 | $9K | Sell |
16,680
-5,159
| -24% | -$2.77K | ﹤0.01% | 2821 |
|
|
2019
Q2 | $11K | Buy |
21,839
+28
| +0.1% | +$14 | ﹤0.01% | 2760 |
|
|
2019
Q1 | $9K | Sell |
21,811
-65
| -0.3% | -$30 | ﹤0.01% | 2734 |
|
|
2018
Q4 | $10K | Sell |
21,876
-46
| -0.2% | -$23 | ﹤0.01% | 2651 |
|
|
2018
Q3 | $11K | Sell |
21,922
-1,150
| -5% | -$617 | ﹤0.01% | 2773 |
|
|
2018
Q2 | $12K | Sell |
23,072
-386
| -2% | -$180 | ﹤0.01% | 2748 |
|
|
2018
Q1 | $9K | Buy |
23,458
+123
| +0.5% | +$49 | ﹤0.01% | 2698 |
|
|
2017
Q4 | $9K | Sell |
23,335
-18,791
| -45% | -$7.13K | ﹤0.01% | 2671 |
|
|
2017
Q3 | $15K | Sell |
42,126
-244
| -0.6% | -$90 | ﹤0.01% | 2538 |
|
|
2017
Q2 | $16K | Buy |
42,370
+111
| +0.3% | +$45 | ﹤0.01% | 2494 |
|
|
2017
Q1 | $19K | Sell |
42,259
-563
| -1% | -$247 | ﹤0.01% | 2390 |
|
|
2016
Q4 | $16K | Buy |
42,822
+28
| +0.1% | +$9 | ﹤0.01% | 2298 |
|
|
2016
Q3 | $12K | Buy |
42,794
+131
| +0.3% | +$33 | ﹤0.01% | 2235 |
|
|
2016
Q2 | $10K | Sell |
42,663
-72
| -0.2% | -$12 | ﹤0.01% | 2220 |
|
|
2016
Q1 | $5K | Buy |
42,735
+54
| +0.1% | +$6 | ﹤0.01% | 2203 |
|
|
2015
Q4 | $5K | Hold |
42,681
| – | – | ﹤0.01% | 2183 |
|
|
2015
Q3 | $8K | Sell |
42,681
-9,253
| -18% | -$3.15K | ﹤0.01% | 2131 |
|
|
2015
Q2 | $36K | Buy |
51,934
+3,104
| +6% | +$2.15K | ﹤0.01% | 2149 |
|
|
2015
Q1 | $33K | Buy |
48,830
+30
| +0.1% | +$21 | ﹤0.01% | 2137 |
|
|
2014
Q4 | $39K | Buy |
48,800
+20,147
| +70% | +$13.8K | ﹤0.01% | 2045 |
|
|
2014
Q3 | $13K | Buy |
28,653
+35
| +0.1% | +$17 | ﹤0.01% | 2079 |
|
|
2014
Q2 | $14K | Sell |
28,618
-9,734
| -25% | -$4.71K | ﹤0.01% | 2048 |
|
|
2014
Q1 | $12K | Buy |
38,352
+1,319
| +4% | +$490 | ﹤0.01% | 1986 |
|
|
2013
Q4 | $13K | Buy |
37,033
+22,062
| +147% | +$26.7K | ﹤0.01% | 1918 |
|
|
2013
Q3 | $30K | Buy |
14,971
+433
| +3% | +$825 | ﹤0.01% | 1838 |
|
|
2013
Q2 | $28K | Buy |
+14,538
| New | +$25.5K | ﹤0.01% | 1771 |
|
Commonwealth Equity Services's GCVRZ Position: Q1 2020 in Review
Commonwealth Equity Services sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 41,260 shares — an estimated $35K sold.
Commonwealth Equity Services first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $39K in Q4 2014. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Commonwealth Equity Services reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Commonwealth Equity Services sold 41,260 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $35K.
- Commonwealth Equity Services first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Commonwealth Equity Services's Sanofi Contingent Value Rights position peaked at $39K in Q4 2014.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Commonwealth Equity Services's 13F filing for Q1 2020, filed 11 May 2020.